Who founded TripleBar Bio, Inc.?

TripleBar Bio, Inc. was founded by Jeremy Agresti in 2019.

Who are TripleBar Bio, Inc.'s investors?

TripleBar Bio, Inc.'s investors include iSelect Fund, Stray Dog Capital, Synthesis Capital, TPB.

How much funding has TripleBar Bio, Inc. raised?

TripleBar Bio, Inc. has disclosed $19.8M raised across 1 round.

Where is TripleBar Bio, Inc. headquartered?

TripleBar Bio, Inc. is headquartered in Emeryville, US.

TripleBar Bio, Inc.

Emeryville, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn · 4 known investors

Find your way into TripleBar Bio, Inc.

Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

TripleBar Bio, Inc. was founded in 2019 by Jeremy Agresti.

Jeremy AgrestiinFounder and CTO

Howard LevinNamed on SEC filing

Maria ChoNamed on SEC filing

Board

Rose WardleBoard directorExecutive Officer at Synthesis Capital

David Friedberg in 𝕏Board directorFounder of The Production Board, a venture foundry and VC firm reimagining Earth through life sciences, food and agriculture, and software

Investors · 4

iSelect FundSt. Louis · $250K – $2M

Stray Dog CapitalLeawood · $100K – $1M

Synthesis CapitalLondon

TPBreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$19.8M disclosed across 1 round · 2023

▶$19.8MraisedOct 2023 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Rose WardleDirector
Howard LevinDirector
David FriedbergDirector
Maria ChoExecutive Officer, Director

Offering amount: $20.5M
Amount sold: $19.8M
First sale: Oct 2023
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

3Bar Biologics7 shared keywords

IQ Bar4 shared keywordsIQBAR makes low-carb, high-fat protein bars and other functional food and drink products focused on brain and body nutrition for people seeking convenient options that fit low-carb diets. Its product range includes protein bars and drink mixes.

32 Biosciences Website4 shared keywordsA biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.

ClickBio, Inc.3 shared keywordsClickBio manufactures laboratory automation hardware and reagent handling equipment for life sciences research, including reagent reservoirs, fill stations, and plate adapters compatible with standard microplate formats.

Companies competing with TripleBar Bio, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does TripleBar Bio, Inc. do?: Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
Who founded TripleBar Bio, Inc.?: TripleBar Bio, Inc. was founded by Jeremy Agresti in 2019.
Who are TripleBar Bio, Inc.'s investors?: TripleBar Bio, Inc.'s investors include iSelect Fund, Stray Dog Capital, Synthesis Capital, TPB.
How much funding has TripleBar Bio, Inc. raised?: TripleBar Bio, Inc. has disclosed $19.8M raised across 1 round.
Where is TripleBar Bio, Inc. headquartered?: TripleBar Bio, Inc. is headquartered in Emeryville, US.